Detalhe da pesquisa
1.
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects.
J Infect Chemother
; 30(3): 271-275, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944697
2.
The effect of post-COVID-19 on gustatory and olfactory function: A preliminary case-controlled study.
Oral Dis
; 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929202
3.
Neutrophil-to-lymphocyte ratio trend at admission predicts adverse outcome in hospitalized respiratory syncytial virus patients.
Heliyon
; 9(6): e16482, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37251466
4.
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond.
EMBO Mol Med
; 14(9): e15997, 2022 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35776000
5.
An Exercise-Induced Metabolic Shield in Distant Organs Blocks Cancer Progression and Metastatic Dissemination.
Cancer Res
; 82(22): 4164-4178, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084256
6.
Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection.
Sci Rep
; 11(1): 21519, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34728719
7.
C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department.
Crit Care
; 13(2): R50, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19351421
8.
B artonella endocarditis masquerading as systemic vasculitis with rapidly progressive glomerulonephritis (aka 'Löhlein nephritis').
BMJ Case Rep
; 12(12)2019 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801777
9.
Time course of anosmia and dysgeusia in patients with mild SARS-CoV-2 infection.
Infect Dis (Lond)
; 52(8): 600-602, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552475